Guilherme Rezende

412 total citations
7 papers, 186 citations indexed

About

Guilherme Rezende is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Guilherme Rezende has authored 7 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Guilherme Rezende's work include Liver Disease and Transplantation (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Organ Transplantation Techniques and Outcomes (2 papers). Guilherme Rezende is often cited by papers focused on Liver Disease and Transplantation (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Organ Transplantation Techniques and Outcomes (2 papers). Guilherme Rezende collaborates with scholars based in Brazil, United Kingdom and Czechia. Guilherme Rezende's co-authors include Regina Coeli dos Santos Goldenberg, Antônio Carlos Campos de Carvalho, José Roberto Lapa e Silva, Juliana Vieira Dias, Taís Hanae Kasai-Brunswick, Henrique Sergio Coelho, James A. Thomas, Sérgio Augusto Lopes de Souza, Ângelo Maiolino and Vera Lúcia Antunes Chagas and has published in prestigious journals such as European Radiology, Liver International and Pancreas.

In The Last Decade

Guilherme Rezende

6 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guilherme Rezende Brazil 5 141 120 75 33 26 7 186
Benjamin M. Stutchfield United Kingdom 7 178 1.3× 80 0.7× 190 2.5× 29 0.9× 45 1.7× 11 285
Kyoko Monoe Japan 8 180 1.3× 147 1.2× 57 0.8× 19 0.6× 7 0.3× 25 228
Shaoli You China 11 203 1.4× 174 1.4× 47 0.6× 44 1.3× 9 0.3× 32 271
Teruko Arinaga‐Hino Japan 9 207 1.5× 199 1.7× 61 0.8× 27 0.8× 4 0.2× 30 261
Jessica P.E. Davis United States 10 157 1.1× 143 1.2× 73 1.0× 17 0.5× 4 0.2× 28 273
Alejandra Villamil Argentina 5 72 0.5× 47 0.4× 24 0.3× 29 0.9× 30 1.2× 15 182
Hua-Mei Wu China 11 165 1.2× 154 1.3× 109 1.5× 29 0.9× 58 2.2× 26 310
Pol Olivas Spain 8 129 0.9× 159 1.3× 71 0.9× 9 0.3× 13 0.5× 18 258
Takahiro Yamaura Japan 9 178 1.3× 252 2.1× 97 1.3× 12 0.4× 7 0.3× 11 340
Zeeshan Ahmad Wani India 5 108 0.8× 102 0.8× 18 0.2× 25 0.8× 10 0.4× 14 153

Countries citing papers authored by Guilherme Rezende

Since Specialization
Citations

This map shows the geographic impact of Guilherme Rezende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilherme Rezende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilherme Rezende more than expected).

Fields of papers citing papers by Guilherme Rezende

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guilherme Rezende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilherme Rezende. The network helps show where Guilherme Rezende may publish in the future.

Co-authorship network of co-authors of Guilherme Rezende

This figure shows the co-authorship network connecting the top 25 collaborators of Guilherme Rezende. A scholar is included among the top collaborators of Guilherme Rezende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guilherme Rezende. Guilherme Rezende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Parente, Daniella Braz, et al.. (2023). Relative enhancement index can be used to quantify liver function in cirrhotic patients that undergo gadoxetic acid–enhanced MRI. European Radiology. 33(7). 5142–5149. 3 indexed citations
2.
Dumonceau, Jean‐Marc, et al.. (2021). Rapid On-Site Evaluation by Endosonographer of Endoscopic Ultrasound Fine-Needle Aspiration of Solid Pancreatic Lesions. Pancreas. 50(6). 815–821. 16 indexed citations
3.
Cardoso, Ana Carolina, et al.. (2019). The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort. European Journal of Gastroenterology & Hepatology. 32(2). 231–238. 15 indexed citations
4.
Miyata, Seiji, et al.. (2018). Intraabdominal Gossipiboma: case report. Revista Médica de Minas Gerais. 28.
5.
Rezende, Guilherme, et al.. (2015). Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial. Digestive and Liver Disease. 47(11). 957–963. 91 indexed citations
6.
Goldenberg, Regina Coeli dos Santos, Léa Mirian Barbosa da Fonseca, James A. Thomas, et al.. (2011). Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. Liver International. 31(3). 391–400. 46 indexed citations
7.
Quintanilha, Luiz Fernando, Adriana Bastos Carvalho, Guilherme Rezende, et al.. (2009). Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model. Clinical Transplantation. 25(1). 54–60. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026